VEGFA and cancer: At present, many anti-angiogenic targeted drugs are used in the treatment of malignant tumors, such as the vascular endothelial growth factor (VEGF) monoclonal antibody-Bevacizumab, oligonucleotide aptamers-Pegaptanib, recombinant fusion proteins-Aflibercept, and tyrosine kinase inhibitors.